NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
Elevated preoperative NLR demonstrates significant association with poor survival in post-CN mRCC patients and may facilitate clinical decision-making.
Authors
- Senlin Li (ORCID: https://orcid.org/0000-0002-2665-4171)
- Fan Zhang (ORCID: https://orcid.org/0000-0003-3311-8294)
- Weiyang He (ORCID: https://orcid.org/0000-0002-5265-7595)
- Huanrui Liu
- Xin Gou (ORCID: https://orcid.org/0000-0001-5707-0753)
- Xu Zhang (ORCID: https://orcid.org/0000-0002-3662-7759)
- Yongpeng Xie (ORCID: https://orcid.org/0009-0007-7790-3194)
Institutions
- University of California, Los Angeles (US)
- Chinese PLA General Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1080/17520363.2025.2471746
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Chongqing